论文部分内容阅读
礼莱公司的精神分裂症药奥氮平（Ｚｙｐｒｅｘａ），在今年第二季度的销售中占美国抗精神病药市场的２０％，此举使礼莱公司的销售总额提高１８％。礼莱公司在第二季度全球销售总额为２３亿美元，纯利润为４．９１亿美元。礼莱公司宣称，Ｚｙｐｒｅｘａ及另外４种更新的药...
Lilly’s schizophrenia drug Zyprexa, which accounted for 20% of the US antipsychotic market in the second quarter of this year’s sales, increased the total sales of the company by 18%. In the second quarter, Lilly’s global sales totaled 2.3 billion U.S. dollars and its net profit was 491 million U.S. dollars. Lilly claims that Zyprexa and 4 other newer drugs...